Title : Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epidermal growth factor receptor mutated non-small cell lung cancer.

Pub. Date : 2020 Mar

PMID : 31945708






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epidermal growth factor receptor mutated non-small cell lung cancer. Tyrosine epidermal growth factor receptor Homo sapiens
2 OBJECTIVES: Epidermal growth factor receptor (EGFR) mutations confer sensitivity to tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC). Tyrosine epidermal growth factor receptor Homo sapiens
3 OBJECTIVES: Epidermal growth factor receptor (EGFR) mutations confer sensitivity to tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC). Tyrosine epidermal growth factor receptor Homo sapiens